Portfolio company
Cognoptix
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops a non-invasive eye scanning system to detect Alzheimer's disease for clinicians and pharmaceutical partners.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Optina Dx
The company develops an artificial intelligence platform and retinal imaging camera for the non-invasive detection of Alzheimer's disease and other systemic conditions for healthcare providers.
Cognito Tx
This company develops non-invasive wearable devices using light and sound stimulation to treat patients with Alzheimer's and other neurodegenerative diseases.
RetiSpec
This company develops artificial intelligence software for retinal imaging to help clinicians detect biomarkers of Alzheimer's disease and other neurodegenerative conditions.
Cogniguard
This company develops non-invasive vagus nerve stimulation medical devices to treat patients with Alzheimer's disease and mild cognitive impairment.
ViewMind
ViewMind develops eye-tracking cognitive assessment tools for pharmaceutical researchers and healthcare providers to detect and monitor neurodegenerative diseases and brain health.
Applied Cognition
The company develops non-invasive glymphatic system monitoring platforms and drug therapies for patients with neurological disorders like Alzheimer's and Parkinson's.
Cytox
This company develops non-invasive genetic tests for Alzheimer's disease risk assessment and patient stratification for clinicians and pharmaceutical researchers.
Optina Diagnostics
This company develops artificial intelligence platforms and hyperspectral retinal imaging cameras to help eye specialists diagnose and manage retinal and neurodegenerative diseases.
